Scalpel Weekly News

Week of: June 25, 2018

IN THE NEWS


Compounded Eye Injection Adverse Events; Cataract Surgery

On June 14, 2018, the FDA alerted health professionals that at least 43 patients reported adverse events after receiving eye injections of Guardian’s Pharmacy Services’ compounded triamcinolone-moxifloxacin product during cataract surgery. The patients reportedly experienced various symptoms, including vision impairment, poor night vision, loss of color perception, and significant reductions in best-corrected visual acuity and visual fields. Click title to continue reading...


 
MEDICAL ALERTS


First Generic Versions of Opioid Dependence Treatment

On June 14, 2018, the FDA granted Mylan Technologies Inc. and Dr. Reddy’s Laboratories SA approval to market multiple strengths of the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. Click title to continue reading...



International Outbreak of Salmonella; Kellogg’s Cereal Link

On June 15, 2018, the FDA advised consumers to not eat and to discard any Kellogg’s Honey Smacks cereal. This is regardless of size or “best if used by” dates. The Kellogg Company recalled Kellogg’s Honey Smacks to prevent further distribution of potentially contaminated products. The recall notice accounted for all of the product that was on the market within the cereal’s estimated one year shelf-life. However, Honey Smacks products with earlier dates could also potentially be contaminated. Click title to continue reading...



More Obesity in Rural Counties than Urban Counties

On June 14, 2018, the CDC published a report that found that adults living in non-metropolitan (rural) counties are still more likely to be obese than adults in metro (urban) counties. Approximately 46 million persons (14 percent) in the United States live in nonmetropolitan counties. Compared with metropolitan residents, nonmetropolitan residents have a higher prevalence of obesity-associated chronic diseases such as diabetes, coronary heart disease, and arthritis. Click title to continue reading...


  CASE ALERTS


Failure to Disclose Surgeon Inexperience; Informed Consent

A man underwent a Bentall procedure, a cardiac surgery to treat combined aortic valve and ascending aorta disease involving replacement of the aortic valve, aortic root, and ascending aorta. The cardiovascular surgeon who performed the procedure had no previous experience or training in performing a Bentall procedure. Several complications resulted in the man becoming comatose, undergoing a second heart surgery, and undergoing a heart transplant. Click title to continue reading...



Failure to Diagnose Surgical Site Infection; Knee Replacement

An orthopedic surgeon performed arthroscopic surgery on a woman’s knee. At the woman’s post-surgery follow-up appointment about two weeks later, the woman reported to the orthopedic surgeon’s physician’s assistant (PA) swelling in the knee. The PA recommended that the woman attend physical therapy to treat the symptoms. Click title to continue reading...



Out-of-Network Hospital Stated ERISA Claim Against Insurers

Insured patients presented to an out-of-network hospital for healthcare services. Before providing services, the hospital verified with the respective insurers that the healthcare services were covered by insurance. The hospital provided healthcare services to the insured patients. The insurers did not reimburse the hospital for the services provided at the rate the hospital expected. The insureds assigned their right of payment of monies under the health insurance plans to the hospital. Click title to continue reading...


FEATURE


Checklist: Defendant’s Discovery-Compounded Drug Injury

As a special feature for our Premium subscribers we have included this feature containing a checklist of information counsel for a pharmacist should gather to defend against a medical malpractice action alleging injuries caused by an improperly compounded drug. Click title to continue reading...